查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869728

生物製程自動化市場規模、佔有率和趨勢分析報告：按產品/服務、製程階段、最終用途、地區和細分市場預測（2025-2033 年）

Bioprocess Automation Market Size, Share & Trends Analysis Report By Product & Services, By Process Stage, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

生物製程自動化市場摘要

2024年全球生物過程自動化市場規模估計為77.6億美元，預計2033年將達到224.1億美元。

預計從 2025 年到 2033 年，該行業將以 12.67% 的複合年成長率成長，這主要得益於對生物製藥的需求不斷成長、人工智慧和機器人技術的進步，以及對監管合規性和效率的需求。

生物製藥需求不斷成長

生物製劑需求的不斷成長是生物製程自動化產業最重要的驅動力之一。過去十年，由於單株抗體、疫苗、基因療法和其他生物製劑在治療包括癌症、自體免疫疾病和罕見遺傳疾病在內的複雜疾病方面的有效性，其研發和應用呈爆炸式成長。為了確保這些生物製劑保持有效性和高品質，生產過程必須嚴格控制、擴充性且精準。傳統的手動或半自動生產方法通常勞動密集、容易出錯，且無法滿足不斷成長的市場需求，因此迫切需要全自動生物製程解決方案。

隨著全球醫療保健系統越來越依賴生物學來開發新型療法，生物製程自動化的需求預計將會成長，並已成為現代製藥生產的重要組成部分。生物製程自動化使製造商能夠在不影響品質的前提下最佳化生產流程、提高一致性並增加產量。透過整合機器人、人工智慧和先進的監控系統，生物製藥公司可以以更低的變異性、更短的交貨時間和更低的營運成本，大規模生產生物製藥。

提高效率和降低成本的必要性

降低成本和提高效率的需求是生物製程自動化市場的主要驅動力。生物製藥生產是一個複雜且資源密集的過程，通常需要高素質的員工、細緻的監管和嚴格的通訊協定遵循。人工或半自動化流程勞力密集且容易出現人為錯誤，可能導致批次失敗、產品品質不穩定以及生產成本增加。透過實施自動化系統，企業可以提高生產效率，減少對人工的依賴，最大限度地減少錯誤，並確保各生產批次的結果更加一致可靠。

自動化能夠提高生產效率、顯著降低營運成本並提升可靠性。自動化生物製程系統可實現連續運行，最大限度地減少停機時間，最佳化資源利用，並加快生產週期，從而使製造商能夠更有效地滿足不斷成長的市場需求。在醫療保健產業成本意識日益增強的今天，以低成本生產高品質生物製藥的能力也有助於企業保持競爭力。因此，對成本效益和營運效率的需求持續推動全球對生物製程自動化技術的投資。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 附隨市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素的影響分析
    • 市場限制因素的影響分析
  • 商業環境分析
    • PESTLE分析
    • 波特五力分析

第4章 產品與服務業務分析

  • 產品和服務細分儀表板
  • 全球生物過程自動化市場：產品與服務、差異分析
  • 全球生物製程自動化市場規模及趨勢分析（按產品和服務分類，2021-2033 年）
  • 自動化耗材和配件
  • 流程自動化硬體
  • 軟體和控制系統
  • 整合式承包解決方案
  • 服務與支援

第5章：流程階段業務分析

  • 流程階段細分儀表板
  • 全球生物過程自動化市場製程階段及變異分析
  • 全球生物製程自動化市場規模及趨勢分析（依製程階段分類，2021-2033 年）
  • 上游
  • 下游
  • 製程開發和放大
  • 填充/包裝自動化
  • 品管和流程自動化技術

第6章 最終用戶業務分析

  • 最終用戶細分儀表板
  • 全球生物過程自動化市場最終用途及變化分析
  • 全球生物製程自動化市場規模及趨勢分析（依最終用途分類，2021-2033 年）
  • 製藥和生物技術製造商
  • CDMO 和 CMO
  • 學術研究機構
  • 合約測試和分析實驗室
  • 其他

第7章 生物製程自動化市場：區域估算與趨勢分析，依產品、產品與服務、最終用途、最終用途

  • 區域儀錶板
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 2021-2033年北美生物製程自動化市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲生物過程自動化市場，2021-2033年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區生物過程自動化市場，2021-2033年
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2021-2033年拉丁美洲生物過程自動化市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東及非洲生物製程自動化市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司分類
  • 策略規劃
  • 企業市場分析，2024年
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Parker Hannifin Corp
    • Merck KGaA
    • Eppendorf SE
    • SIA Bioreactors.net
    • Senieer
    • Getinge
    • Repligen Corporation
Product Code: GVR-4-68040-764-1

Bioprocess Automation Market Summary

The global bioprocess automation market size was estimated at USD 7.76 billion in 2024 and is projected to reach USD 22.41 billion by 2033, growing at a CAGR of 12.67% from 2025 to 2033, driven by rising demand for biologics, advancements in AI and robotics, and the need for regulatory compliance and efficiency.

Rising Demand for Biologics

The rising demand for biologics is among the most significant drivers of the bioprocess automation industry. Over the past decade, there has been a sharp increase in the development and use of monoclonal antibodies, vaccines, gene therapies, and other biologic products due to their effectiveness in treating complex diseases, including cancer, autoimmune disorders, and rare genetic conditions. For these biologics to remain effective and to maintain high quality, manufacturing procedures must be extremely controlled, scalable, and precise. There is a significant need for fully automated bioprocess solutions because traditional manual or semi-automated production methods are frequently labor-intensive, prone to mistakes, and inadequate to meet the expanding market demand.

The need for bioprocess automation is anticipated to increase as the world's healthcare system depends more on biology for novel treatments, making it an essential part of contemporary pharmaceutical production. Automation in bioprocessing allows manufacturers to optimize production workflows, improve consistency, and increase throughput without compromising quality. Biopharmaceutical companies can produce larger biologics with reduced variability, faster turnaround times, and lower operational costs by integrating robotics, AI, and advanced monitoring systems.

Need for Efficiency and Cost Reduction

The need for cost and efficiency reduction largely drives the market for bioprocess automation. Manufacturing biopharmaceuticals is a complicated and resource-intensive process that frequently requires highly qualified staff, careful observation, and strict protocol adherence. Batch failures, inconsistent products, and higher production costs can result from labor-intensive, human error-prone manual or semi-automated processes. By implementing automated systems, businesses can increase productivity, decrease reliance on manual labor, and minimize errors, guaranteeing more consistent and dependable results across production batches.

Automation increases productivity, drastically reduces operating costs, and improves reliability. Manufacturers can more effectively meet growing market demand thanks to automated bioprocessing systems' ability to run continuously with little downtime, optimize resource usage, and speed up production cycles. In an increasingly cost-sensitive healthcare environment, the ability to produce high-quality biologics at a lower cost also helps businesses stay competitive. As a result, the need for cost-effectiveness and operational efficiency keeps driving global investments in bioprocess automation technologies.

Global Bioprocess Automation Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global bioprocess automation market report based on product & service, process stage, end use, and region:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Automation Consumables & Accessories
  • Process Automation Hardware
  • Software & Control Systems
  • Integrated & Turnkey Solutions
  • Services & Support
  • Process Stage Outlook (Revenue, USD Million, 2021 - 2033)
  • Upstream
  • Downstream
  • Process Development & Scale-up
  • Fill/Finish & Packaging automation
  • Quality Control & PAT
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & biotech manufacturers
  • CDMOs & CMOs
  • Academic & research institutions
  • Contract testing & analytical labs
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Services
    • 1.2.2. Process Stage
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Details
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Impact Analysis
      • 3.3.1.1. Rising demand for biologics
      • 3.3.1.2. Need for efficiency and cost reduction
    • 3.3.2. Market Restraint Impact Analysis
      • 3.3.2.1. High Initial Investment Costs
      • 3.3.2.2. Regulatory and Compliance Challenges
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Product & Services Business Analysis

  • 4.1. Product & Services Segment Dashboard
  • 4.2. Global Bioprocess Automation Market Product & Services, Movement Analysis
  • 4.3. Global Bioprocess Automation Market Size & Trend Analysis, by Product & Services, 2021 to 2033 (USD Million)
  • 4.4. Automation Consumables & Accessories
    • 4.4.1. Global automation consumables & accessories market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Process Automation Hardware
    • 4.5.1. Global Process Automation Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Software & Control Systems
    • 4.6.1. Global software & control systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Integrated & Turnkey Solutions
    • 4.7.1. Global integrated & turnkey solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Services & Support
    • 4.8.1. Global services & support market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Process Stage Business Analysis

  • 5.1. Process Stage Segment Dashboard
  • 5.2. Global Bioprocess Automation Market Process Stage, Movement Analysis
  • 5.3. Global Bioprocess Automation Market Size & Trend Analysis, by Process Stage, 2021 to 2033 (USD Million)
  • 5.4. Upstream
    • 5.4.1. Global upstream market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Downstream
    • 5.5.1. Global downstream market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Process Development & Scale-up
    • 5.6.1. Global process development & scale-up market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Fill/Finish & Packaging automation
    • 5.7.1. Global fill/finish & packaging automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.8. Quality Control & PAT
    • 5.8.1. Global quality control & PAT market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Bioprocess Automation Market End Use, Movement Analysis
  • 6.3. Global Bioprocess Automation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & biotech manufacturers
    • 6.4.1. Global Pharmaceutical & biotech manufacturers market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. CDMOs & CMOs
    • 6.5.1. Global CDMOs & CMOs market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Academic & research institutions
    • 6.6.1. Global academic & research institutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Contract testing & analytical labs
    • 6.7.1. Global contract testing & analytical labs market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Global others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Bioprocess Automation Market: Regional Estimates and Trend Analysis, by Product, Product & Services, End Use, & End-Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. U.S. bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Canada bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Mexico bioprocess automation market, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. UK bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Germany bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. France bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Italy bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Spain bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Denmark bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Sweden bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Target Disease Prevalence
      • 7.4.9.3. Competitive Scenario
      • 7.4.9.4. Regulatory Framework
      • 7.4.9.5. Norway bioprocess automation market, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Japan bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. China bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. India bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Australia bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Regulatory Framework
      • 7.5.6.5. Thailand bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Regulatory Framework
      • 7.5.7.5. South Korea bioprocess automation market, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. Brazil bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Argentina bioprocess automation market, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Regulatory Framework
      • 7.7.2.5. South Africa bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Regulatory Framework
      • 7.7.3.5. Saudi Arabia bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Target Disease Prevalence
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Regulatory Framework
      • 7.7.4.5. UAE bioprocess automation market, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Target Disease Prevalence
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. Regulatory Framework
      • 7.7.5.5. Kuwait bioprocess automation market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Sartorius AG
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Parker Hannifin Corp
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Merck KGaA
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Eppendorf SE
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. SIA Bioreactors.net
      • 8.4.6.1. Overview
      • 8.4.6.2. Product Benchmarking
      • 8.4.6.3. Strategic Initiatives
    • 8.4.7. Senieer
      • 8.4.7.1. Overview
      • 8.4.7.2. Product Benchmarking
      • 8.4.7.3. Strategic Initiatives
    • 8.4.8. Getinge
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Repligen Corporation
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 4. Global Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 5. Global Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 6. Global Bioprocess Automation Market, by Region, 2021 - 2033 (USD Million)
  • Table 7. North America Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million)
  • Table 8. North America Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 9. North America Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 10. North America Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 11. U.S. Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 12. U.S. Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 13. U.S. Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 14. Canada Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 15. Canada Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 16. Canada Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 17. Mexico Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 18. Mexico Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 19. Mexico Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20. Europe Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million)
  • Table 21. Europe Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 22. Europe Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 23. Europe Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 24. Germany Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 25. Germany Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 26. Germany Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 27. UK Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 28. UK Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 29. UK Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30. France Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 31. France Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 32. France Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 33. Italy Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 34. Italy Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 35. Italy Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 36. Spain Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 37. Spain Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 38. Spain Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 39. Denmark Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 40. Denmark Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 41. Denmark Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 42. Norway Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 43. Norway Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 44. Norway Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 45. Sweden Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 46. Sweden Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 47. Sweden Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 51. Asia Pacific Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 52. China Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 53. China Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 54. China Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 55. Japan Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 56. Japan Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 57. Japan Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 58. India Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 59. India Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 60. India Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61. South Korea Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 62. South Korea Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 63. South Korea Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 64. Australia Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 65. Australia Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 66. Australia Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 67. Thailand Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 68. Thailand Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 69. Thailand Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 70. Latin America Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million)
  • Table 71. Latin America Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 72. Latin America Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 73. Latin America Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 74. Brazil Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 75. Brazil Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 76. Brazil Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 77. Argentina Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 78. Argentina Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 79. Argentina Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 80. Middle East and Africa Bioprocess Automation Market, by Country, 2021 - 2033 (USD Million)
  • Table 81. Middle East and Africa Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 82. Middle East and Africa Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 83. Middle East and Africa Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 84. South Africa Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 85. South Africa Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 86. South Africa Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 90. UAE Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 91. UAE Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 92. UAE Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)
  • Table 93. Kuwait Bioprocess Automation Market, by Product & Services, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Bioprocess Automation Market, by Process Stage, 2021 - 2033 (USD Million)
  • Table 95. Kuwait Bioprocess Automation Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Bioprocess automation market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validation & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 Bioprocess automation market: Product & Services outlook key takeaways
  • Fig. 19 Bioprocess automation market: Product & Services movement analysis
  • Fig. 20 Automation consumables & accessories market, 2021 - 2033 (USD Million)
  • Fig. 21 Process automation hardware market, 2021 - 2033 (USD Million)
  • Fig. 22 Software & control systems market, 2021 - 2033 (USD Million)
  • Fig. 23 Integrated & turnkey solutions market, 2021 - 2033 (USD Million)
  • Fig. 24 Services & support market, 2021 - 2033 (USD Million)
  • Fig. 25 Bioprocess automation market: Process Stage outlook key takeaways
  • Fig. 26 Bioprocess automation market: Process Stage movement analysis
  • Fig. 27 Upstream market, 2021 - 2033 (USD Million)
  • Fig. 28 Downstream market, 2021 - 2033 (USD Million)
  • Fig. 29 Process development & scale-up market, 2021 - 2033 (USD Million)
  • Fig. 30 Fill/finish & packaging automation market, 2021 - 2033 (USD Million)
  • Fig. 31 Quality control & PAT market, 2021 - 2033 (USD Million)
  • Fig. 32 Bioprocess automation market: End Use outlook key takeaways
  • Fig. 33 Bioprocess automation market: End Use movement analysis
  • Fig. 34 Pharmaceutical & biotech manufacturers market, 2021 - 2033 (USD Million)
  • Fig. 35 CDMOs & CMOs market, 2021 - 2033 (USD Million)
  • Fig. 36 Academic & research institutions market, 2021 - 2033 (USD Million)
  • Fig. 37 Contract testing & analytical labs market, 2021 - 2033 (USD Million)
  • Fig. 38 Others market, 2021 - 2033 (USD Million)
  • Fig. 39 Regional marketplace outlook, 2024 & 2033 (USD Million)
  • Fig. 40 Regional marketplace: Key takeaways
  • Fig. 41 North America bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 U.S. bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Canada bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Mexico bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Europe bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Germany bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 UK bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 France bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Spain bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Sweden bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Asia Pacific bioprocess automation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Japan bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 China bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 India bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 South Korea bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Australia bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Thailand bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Latin America bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Brazil bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Argentina bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 MEA bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 South Africa bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Saudi Arabia bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 UAE bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Kuwait bioprocess automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Market position analysis
  • Fig. 93 Market participant categorization
  • Fig. 94 Strategic framework